CMV plasma DNAemia and risk of cancer among HIV-infected patients: a case-control study nested in the ANRS CO3 Aquitaine Cohort, France, 2002-2007.

Background: CMV reactivation, which enhances immune senescence, could be associated with a higher risk of cancer.

Objectives: We compared the prevalence of positive CMV DNAemia in HIV-infected patients with and without cancer.

Study Design: This case-control study, nested in the ANRS-CO3 Aquitaine Cohort, included patients with a first diagnosis of cancer (2002-2007) as cases.